Dr. Reddy’s Laboratories on Tuesday posted $2.2 billion in annual sales for the fiscal year ended March 31, representing growth of 14%.
Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.
The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.
Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.
Dr. Reddy's Labs has received regulatory approval from the Food and Drug Administration for generic versions of treatments for Alzheimer's disease, depression and breast cancer.
Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.
The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.
The Food and Drug Administration has approved a generic treatment for Alzheimer’s disease made by Actavis, the drug maker said Tuesday.
Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.
Ranbaxy Pharmaceuticals has received final approval for its generic Alzheimer's drug from the Food and Drug Administration, giving the drug maker 180 days of market exclusivity.
Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...
The Food and Drug Administration has accepted for review a regulatory approval application for a...
The generics division of Pfizer will sell an authorized generic version of a drug used...
Hopes that a drug Soviet scientists created in the 1980s might provide a treatment for...